Published in Obesity and Diabetes Week, December 4th, 2006
"However, it has recently been questioned for its low specificity in obese subjects, and now BMI-dependent cut-off levels...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.